These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10473809)

  • 1. Generation of protective immunity against an immunogenic carcinoma requires CD40/CD40L and B7/CD28 interactions but not CD4(+) T cells.
    Eck SC; Turka LA
    Cancer Immunol Immunother; 1999 Sep; 48(6):336-41. PubMed ID: 10473809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aggressive skin allograft rejection in CD28-/- mice independent of the CD40/CD40L costimulatory pathway.
    Ha J; Bingaman AW; Durham MM; Pearson TC; Larsen CP
    Transpl Immunol; 2001 Oct; 9(1):13-7. PubMed ID: 11680567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of CD4 T cell changes in murine AIDS is dependent on costimulation and involves a dysregulation of homeostasis.
    Yen MH; Lepak N; Swain SL
    J Immunol; 2002 Jul; 169(2):722-31. PubMed ID: 12097374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous blockade of B7-CD28 and CD40-CD40L costimulation eliminates the direct xenorestricted human anti-porcine T-cell response.
    Popma SH; Krasinskas AM; Kreisel D; Szeto W; McLean AD; Moore JS; Rosengard BR
    Transplant Proc; 2001; 33(1-2):767-9. PubMed ID: 11267061
    [No Abstract]   [Full Text] [Related]  

  • 5. Blockade of costimulation prevents infection-induced immunopathology in interleukin-10-deficient mice.
    Villegas EN; Wille U; Craig L; Linsley PS; Rennick DM; Peach R; Hunter CA
    Infect Immun; 2000 May; 68(5):2837-44. PubMed ID: 10768980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different costimulation signals used by CD4(+) and CD8(+) cells that independently initiate rejection of allogenic hepatocytes in mice.
    Gao D; Li J; Orosz CG; Bumgardner GL
    Hepatology; 2000 Nov; 32(5):1018-28. PubMed ID: 11050052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
    J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Without CD4 help, CD8 rejection of pig xenografts requires CD28 costimulation but not perforin killing.
    Zhan Y; Brady JL; Sutherland RM; Lew AM
    J Immunol; 2001 Dec; 167(11):6279-85. PubMed ID: 11714791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited importance of CD40/CD40L interaction in the B7-dependent generation of anti-MOPC-315 cytotoxic T lymphocyte activity by tumor bearer splenic cells stimulated in vitro in the presence of tumor necrosis factor.
    Kalinichenko TV; Mokyr MB
    Cancer Immunol Immunother; 1998 Aug; 46(6):293-303. PubMed ID: 9756413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
    Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
    J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis.
    Liu Z; Geboes K; Hellings P; Maerten P; Heremans H; Vandenberghe P; Boon L; van Kooten P; Rutgeerts P; Ceuppens JL
    J Immunol; 2001 Aug; 167(3):1830-8. PubMed ID: 11466409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term survival of rat to mouse cardiac xenografts with prolonged blockade of CD28-B7 interaction combined with peritransplant T-cell depletion.
    Rehman A; Tu Y; Arima T; Linsley PS; Flye MW
    Surgery; 1996 Aug; 120(2):205-12. PubMed ID: 8751584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4 help-independent induction of cytotoxic CD8 cells to allogeneic P815 tumor cells is absolutely dependent on costimulation.
    Zhan Y; Corbett AJ; Brady JL; Sutherland RM; Lew AM
    J Immunol; 2000 Oct; 165(7):3612-9. PubMed ID: 11034363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of CD40 ligand in costimulation and T-cell activation.
    Grewal IS; Flavell RA
    Immunol Rev; 1996 Oct; 153():85-106. PubMed ID: 9010720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic characterization of strain differences in the ability to mediate CD40/CD28-independent rejection of skin allografts.
    Williams MA; Trambley J; Ha J; Adams AB; Durham MM; Rees P; Cowan SR; Pearson TC; Larsen CP
    J Immunol; 2000 Dec; 165(12):6849-57. PubMed ID: 11120808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutting edge: the relative distribution of T cells responding to chemically dominant or minor epitopes of lysozyme is not affected by CD40-CD40 ligand and B7-CD28-CTLA-4 costimulatory pathways.
    DiPaolo RJ; Unanue ER
    J Immunol; 2002 Sep; 169(6):2832-6. PubMed ID: 12218093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative effect of CTLA-4 on induction of T-cell immunity in vivo to B7-1+, but not B7-2+, murine myelogenous leukemia.
    LaBelle JL; Hanke CA; Blazar BR; Truitt RL
    Blood; 2002 Mar; 99(6):2146-53. PubMed ID: 11877291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unusual patterns of alloimmunity evoked by allogeneic liver parenchymal cells.
    Bumgardner GL; Orosz CG
    Immunol Rev; 2000 Apr; 174():260-79. PubMed ID: 10807522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transplantation and the CD28/CTLA4/B7 pathway.
    Alegre M; Fallarino F; Zhou P; Frauwirth K; Thistlethwaite J; Newell K; Gajewski T; Bluestone J
    Transplant Proc; 2001; 33(1-2):209-11. PubMed ID: 11266782
    [No Abstract]   [Full Text] [Related]  

  • 20. CTLA-4 blockade synergizes with tumor-derived granulocyte-macrophage colony-stimulating factor for treatment of an experimental mammary carcinoma.
    Hurwitz AA; Yu TF; Leach DR; Allison JP
    Proc Natl Acad Sci U S A; 1998 Aug; 95(17):10067-71. PubMed ID: 9707601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.